INTRODUCTION:: Mycophenolic acid, the active metabolite of the prodrug mycophenolate
mofetil, is widely used as an immunosuppressive agent in transplant patients for the …

In 2 crossover studies, 12 healthy volunteers (6 male/6 female) received a single oral dose
of mycophenolate mofetil (MMF) 1000 mg or an equimolar dose of enteric‐coated …

In liver transplantation, the efficacy of mycophenolate mofetil (MMF) has been confirmed in
clinical trials and studies. However, therapeutic drug monitoring for mycophenolic acid …

In this Article, we describe a fluorescence polarization immunoassay (FPIA) using a new
label—near-infrared fluorescent dye. The developed FPIA method was optimized for the …

BACKGROUND: We described the development and full validation of a rapid, high
throughput sensible and accurate UPLC method using tandem mass spectrometry detection …

Measuring the concentration of the pharmacologically active metabolite of mycophenolic
acid (MPA), acyl-MPAG (AcMPAG), in addition to the pharmacologically inactive phenol …

The objective of this study is to investigate the correlation between methods of high-
performance liquid chromatography (HPLC) and enzyme multiplied immunoassay …

BACKGROUND: Mycophenolate mofetil (MMF) is a morpholinoethyl ester of mycophenolic
acid (MPA), which is widely used as an immunosuppressive agent in renal transplant …

The aim was to develop a LC/MS/MS method able to quantify mycophenolic acid (MPA) in
the peripheral blood mononuclear cells (PBMCs) of transplanted patients. PBMCs were …

BACKGROUND AND OBJECTIVE: Difference in the hydrophilic properties of mycophenolic
acid metabolites makes it technically difficult to simultaneously determine their plasma levels …